Advanced Filters
noise

hemophilia Clinical Trials

A listing of hemophilia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 99 clinical trials
D Danielle Drury-Stewart, PhD

Hemophilia A Research Program

This study longitudinally observes the intergenerational (mother-child) continuum in hemophilia A from pregnancy through early childhood. Because the study follows mother-child pairs, the study includes both a maternal cohort and a pediatric cohort. Each cohort has a primary goal: for the mother with a severe hemophilia genotype, the overarching primary …

years of age All Phase N/A
A Andreas C. Strauss, PD Dr. med.

Prevalence of Synovitis in Patients With Haemophilia A

The aim of this study is to evaluate the prevalence of synovitis in adult patients with haemophilia A.

18 years of age Male Phase N/A
A Aernoud Bavinck, MD

Home Monitoring in Hemophilia a

Rationale: A novel point-of-care device capable of measuring factor VIII (FVIII) activity and thrombin generation (TG) is currently under development. Utilization of this device in a home situation could potentially transform hemophilia care and improve patients' autonomy. Objective: To explore the potential consequences of home monitoring of hemostatic parameters in …

12 years of age All Phase N/A
M Mankai Ju

PCC Treatment for Hemophilia Patients With Inhibitor(2022PCC-A)

This study is a multicenter, prospective, single-arm exploratory clinical trial designed to evaluate the efficacy and safety of prothrombin complex concentrate (PCC) in the treatment of bleeding episodes in patients with hemophilia A with inhibitors. All participants received on-demand PCC therapy during bleeding episodes, with dosing adjusted by investigators according …

12 - 65 years of age All Phase 4
R Rubén Cuesta-Barriuso, PhD

Multidimensional Assessment of Chronic Pain in Severe Haemophilia A

Introduction: Haemophilia is a congenital coagulopathy characterised by haemarthrosis, mainly in the knees, ankles and elbows. Prophylactic treatment is the most effective therapeutic option for preventing or minimising these bleeds. Bispecific monoclonal antibodies have been shown to be effective in reducing bleeding in patients with haemophilia. Objectives: To investigate the …

18 years of age Male Phase N/A
G Giuseppina Farella

Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From Haemophilia

The present study aims to evaluate the modification of functional capacity induced by an adapted physical activity program in subjects with haemophilia. The exercise program used aims to improve joint mobility, muscle strength, static and dynamic balance, motor coordination. The program is structured in 1 hour sessions of 2 days/week …

18 - 80 years of age All Phase N/A
J Jun L Liu, MD

Gene Therapy for Chinese Hemophilia A

IHBDH-GTHA-2020 is an open- label, non- randomized study to evaluate the safety, tolerability and kinetics of a single intravenous infusion of GS001 in hemophilia A subjects with \<1 IU/dl residual FVIII levels.

18 years of age Male Phase N/A
L Lize van, MD, PhD

Synovial Proliferation on Routine Ultrasound: Active or Inactive?

There is cumulating evidence for the presence of non-observed or subclinical joint bleeding in patients with haemophilia. Early detection of active subclinical synovial proliferation would allow early intervention in order to prevent deterioration of joint health. Patients with subclinical (=non-observed) signs of synovial proliferation in knee(s), ankle(s) and/or elbow(s) will …

12 years of age Male Phase N/A
L Lise Laclautre

Chronic Pain and Hemophilia

Hemophilia (A and B) are X-linked hereditary bleeding disorders whose severity depends on the level of coagulation factor (FVIII or FIX respectively). Bleeding is mainly from joints (hemarthrosis) and muscles (hematoma). Nowadays, treatment is based on preventive or curative intravenous infusion of coagulation factor concentrates. Despite these treatments, there is …

18 years of age All Phase N/A
R Ruud Knols, PhD

Measurement Properties in People with Hemophilia

The aim of this project is to determine the measurement properties (namely reliability and validity) of a set of clinical assessments, measuring different aspects of physical function.

18 years of age All Phase N/A

Simplify language using AI